Replies

That trials ended two months ago isn’t sufficient to discount a year’s worth of trial data from around the world.
~~~~~~~~~~~~~
The design of the early trials is sufficient to discount them from determining efficacy. Moderna had Phase I trials with 15 persons at each of two separate doses, and 16 people in a control group. This is meaningless as to efficacy.
Their Phase II trial was statistically anemic. A real phase II would last about a year or more and they would be expected to have around 2 thousand participants. But theirs lasted 2 months and had about 600 people in it. These are ‘trials’ in name only - the pharmas are phoning it in, assured they’ll make it to administration even lacking sufficient rigor.
Phase III for Pfizer is still in progress and won’t be finished for a year or two, but that’s the phase in which they claim they evaluate efficacy - they just make up the rules for these EUA’s. Ordinarily they’d be expected to research for about 12 years before making efficicacy and safety statements.

Now it’s just whatever they want to say, the CDC will underwrite.

So Moderna’s phase III was 2 months and I recently saw follow up information from month 6 which seems to erase their efficacy claims, but I lost track of it.

Fauci/CDC/Pharma are stating it’s safe without any evidence, and sneering at concerns about safety as ‘baseless’.